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Conclusions: The choice of the appropriate method of 
irradiation (3DCRT vs dynamic techniques) and using the 
appropriate margin determining the image verification 
method (daily verification vs verification for the first 
fractions) significantly affects the average doses in the 
bladder and rectum. 
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Purpose/Objective: Radiation-induced dysphagia is an 
undesirable toxicity in head and neck cancer (HNC) 
treatment. Radiotherapy (RT) delivered with HT might 
mitigate this toxicity. This is a retrospective review of HT 
treatment plans relating planning target volumes (PTVs) and 
organs-at-risk (OAR) dosimetry to severe toxicities.  
Materials and Methods: Seventy two HNC patients treated 
with curative HT were included, 55% of whom had stage IV 
disease and 47% localised in the oral cavity and oropharynx. 
Dose for definitive RT was 70 Gy and for post-operative RT 
60-66 Gy. 47% of patients received a simultaneously 
integrated boost. Severe G3-4 early and chronic toxicities 
(CTCAE version 3.0 and RTOG/EORTC scoring system) were 
scored and correlated with common risk factors. Dose 
distributions to PTVs and OARs were correlated to severe 
toxicities and treatment effectiveness, using COX regression 
and contingency analysis. Overall treatment time of radiation 
therapy (TTT) was reported, with 10 patients having been 
replanned during RT due to anatomical changes.  
Results: Age resulted in more acute severe toxicity. Older 
patients (>64y) had more pain and xerostomia (p=<0.0001) 
and younger patients had more dysphagia and dermitis 
(p=<0.0001) in a multivariate analysis. Median pathologic PTV 
volume was 131 cc (109-153 cc) and elective PTV 345cc (288-
402cc). We achieved excellent pathologic PTV coverage with 
the isodoses 95%, 98% and 2% covering 98%, 97% and 103% of 
volume, respectively. Isodoses 95%, 98% and 2% of elective 
PTV covered 100%, 98% and 127% of volume.  Severe early 
toxicities were 31% mucositis, 11% pain, 7% xerostomia, 52% 
dysphagia and 45% dermitis; 21% of patients developed severe 
chronic dysphagia. Larger p. PTVs (>131 cc) resulted in 
significant higher early dysphagia rates (64.8% vs. 35.14% 
(p=0.02)) and late dysphagia rates (47.9% vs. 52% (p=0.059)). 
Wider PTVs showed a trend of correlation to decreased 
overall survival rates (OS at 3y, 36% vs.74% (p=0.23)). 
Concerning TTT, only 24% of patients had a standard 
treatment duration (<47 days), 40% had an intermediate TTT 
prolongation deviation (47 to 54 days) and 8% an important 
TTT prolongation (>54 days) in TTT, with 29% of patients 
start treatment on Thursday or Friday. TTT was not related 
with acute or late severe toxicities, neither with OS. Patients 
replanned during treatment (10 p) experienced more acute 
toxicity (pain and xerostomia p<0.01), but not an improved in 
locorregional control or OS. Replanning induced significant 
longer TTT (p=0.0001).  
Conclusions: The use of HT improves the coverage of PTV 
volumes preserving salivary glands, even in great volumes. 
Higher doses to ipsilateral parotid (28Gy) and submaxilar 
gland (58Gy) seem to be related to severe toxicity. 
Replanification is related to more toxicity without 
improvement in disease control. Different toxicities by ages 
can be related with other factors like HPV presence (younger 
patients) and basal atrophic salivary glands (older patients). 
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Purpose/Objective: This study aims to evaluate the 
geometric and actual dose delivery accuracy in supine and 
prone positions of breast tomotherapy. 
Materials and Methods: Forty early breast cancer patients 
were recruited for tomotherapy after breast conservation 
surgery. The breast cup size was ≥ C and TNM staging was T0-
T3, N0-N1, M0. All patients received 25 fractions of 
treatment with 2 Gy/fr to total 50 Gy. Thirty were treated in 
supine position on customized vaclok during planning and 
treatment and ten were treated in prone position 
immobilized on prone breast board with customized vaclok. 
Daily MVCT was performed for treatment verification. For 
lateral, longitudinal and vertical dimensions, the offset 
distances in terms of mm before couch adjustment were 
recorded; while for the roll dimension, the degree of angle 
rotated were recorded. The difference in coordinates before 
and after matching in these four dimensional directions were 
recorded in each fraction for each patient. Systematic (SE) 
and random (RE) errors were calculated from the 
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translational differences for comparison. Daily merged CT 
image was created for each patient by substituting the MVCT 
to corresponding portion of planning CT based on the offsets 
obtained during treatment verification. TomoTherapy 
Planned Adaptive software was used to recalculate the daily 
dose distribution on the merged CT. MIM software was used 
to accumulate all recalculated daily doses by deformable 
fusion to give the total actual dose. The mean percentage 
difference (MPD) between the actual and planned doses of 
targets and OARs were then calculated for analysis. 
 
  
Results: The setup deviation in supine position was 
significantly smaller than in prone position, in which the 
lateral, longitudinal, vertical and roll direction were 0.27 vs 
1.53 mm, 0.37 vs 1.23 mm, 0.37 vs 1.34 mm and 0.11 vs 0.43 
° for RE (all p < 0.05), and 2.08 vs 6.32 mm, 2.30 vs 4.62 
mm, 3.14 vs 4.61 mm and 0.31 vs 1.13 ° for SE respectively 
(all p < 0.05 except vertical direction). All dose results are 
shown in Table 1. For prone position, the MPDs of both CTV 
and PTV were significantly smaller in D2% (p = 0.0413), but 
they were greater in D95% and D98% in which PTV D98% showed 
significant difference (p = 0.0215). The opposite signs in MPD 
of D2% and D95%/ D98% in prone position implied the loss of 
target homogeneity. For OAR doses, the MPD were smaller in 
supine than in prone position except Dmean of contralateral 
breast and liver and V15Gy of heart. The actual heart dose was 
in fact increased in prone position (+ve MPD) while decreased 
in supine position. No significant results were found in MPD of 
all OARs.  
Conclusions: Supine position was found to have better 
geometric accuracy. The MPDs for most of the targets and 
OARs in supine position are smaller than that in prone 
position, implying higher accuracy in delivering the planned 
dose. All these suggested supine setup gain more patient 
stability during actual treatment. 
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Purpose/Objective: Comparisons of proton and photon dose 
distributions in treatment plans have clearly demonstrated 
that protons offers superior normal tissue sparing, decreased 
integral dose and excellent dose coverage in craniospinal (CS) 
irradiation (Howell et al, RO, 2012). However, protons are 
especially sensitive to range uncertainties and setup errors 
and have, if not properly accounted for in the planning 
process, the potential of causing large disturbances in the 
planned dose distribution. The aim of this study has been to 
analyse the effect of range uncertainties and setup errors in 
CS proton treatment plans.  
Materials and Methods: Intensity Modulated Proton 
Treatment plans (IMPT) was created for 6 paediatric patients 
in the Eclipse treatment planning system (Varian Medical 
Systems, Palo Alto, CA, USA). The CTV included the whole 
brain and the spinal canal to the junction area between the 
second and third sacral vertebrae. The CTV-PTV margin 
applied was 4 mm, in addition the PTV was expanded to also 
include the entire corpus vertebrae, this to avoid a possibly 
future asymmetric growth of the skeleton (Eifel et al, 
IJROBP, 1995). The beam arrangements consisted of 2 lateral 
oblique fields to cover the brain and the upper cervical 
spine, and 2 posterior fields to enable coverage of the whole 
spinal canal. The prescribed dose was 36 Gy (RBE) in 20 
fractions and evaluated by standard criteria. Setup errors 
were introduced by shifting the isocenter in the treatment 
plans by ±1-5 mm in lateral, longitudinal and vertical 
directions. Range errors was modelled by changing the 
Relative Stopping Power in the CT calibration curve for ±1-5 
%, thus generating a decrease (undershoot) or increase 
(overshoot) in the estimated proton range. The treatment 
plans where then recalculated with the initial spot 
distribution and evaluated in terms of CTV dose coverage and 
the doses to the heart, thyroid and lungs. 
Results: The largest reduction in the CTV dose was caused by 
a 5 mm caudal isocenter shift and an undershoot of 5 %, 
resulting in a reduction in the V95 % from 100 % to 97.7 % and 
97.3%, respectively. This corresponds to a percentage change 
of - 2.3 % and - 2.7 %, respectively (Table I). The heart dose 
was most sensitive to the range uncertainties and setup 
errors in the left direction, increasing the V5Gy(RBE) from 4.2% 
to 6,7 % with 5 mm left isocenter shifts or a 5 % overshoot. 
Range uncertainty had the largest impact on the thyroid 
dose, the V5Gy(RBE) from 50.9% to 72.3 % following a 5% 
overshoot. Only the LR setup error affected the lung dose, 
demonstrated by the increase in V5Gy(RBE) in the right lung due 
to the isocenter shifts in the right direction (Figure 1). 
